🇺🇸 FDA
Pipeline program

Standard lymphodepletion regimen

KYSA-8

Phase 2 mab active

Quick answer

Standard lymphodepletion regimen for Stiff-Person Syndrome is a Phase 2 program (mab) at Kyverna Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Kyverna Therapeutics
Indication
Stiff-Person Syndrome
Phase
Phase 2
Modality
mab
Status
active

Clinical trials